Search
serum sickness; serum sickness-like reaction
Etiology:
- foreign serum, non-human serum proteins
- rabbit anti-thymocyte globulin
- drugs (serum sickness-like reaction, amoxicillin, Augmentin) [3]
- chimeric pharmaceutical monoclonal antibodies containing murine light & heavy chain variable regions & human constant region [2] -infliximab, rituximab
Pathology:
- systemic immune complex formation after administration of drug or foreign serum to patient (type 3 hypersensitivity)
- mediated mainly by IgG
- vascular, cutaneous, cardiac, renal & joint immune complex deposition may result
Clinical manifestations:
1) symptoms may occur from days to 3 weeks after administration of offending agent
- generally occurs within 7-14 days after administration of offending agent
2) fever
3) lymphadenopathy
4) splenomegaly (unlikely with serum sickness-like reactions)
5) pruritic rash, urticaria
- described as 'serpinginous maculopapular eruptions' (NEJM) [5]
6) arthralgias
7) myalgias
8) serum sickness-like reactions less severe than serum sickness
* typically 1-2 weeks for amoxicillin & Augmentin [2]
Complications:
1) glomerulonephritis
2) hepatitis (uncommon)
Differential diagnosis:
- type B drug reaction
- anthralgia uncommon
- unlikely to occur with 1-2 weeks of drug administration [2]
- delayed type hypersensitivity reaction: no fever or arthralgia [5]
- pyrogenic reaction to antivenom
- due to pyrogen contamination in manufacturing
- occur within 1st hour of antivenom administration [5]
Management:
1) symptomatic
2) glucocorticoids
General
type 3 hypersensitivity; immune complex hypersensitivity
adverse drug reaction (ADR)
References
- Taber's Cyclopedic Medical Dictionary, FA Davis, Philadelphia, 1977
- Medical Knowledge Self Assessment Program (MKSAP) 11, 19.
American College of Physicians, Philadelphia 1998, 2021
- NEJM Knowledge+ Question of the Week. Jan 31, 2017
http://knowledgeplus.nejm.org/question-of-week/1250/
- Lin B, Strehlow M.
Images in emergency medicine. Serum sickness-like reaction
to amoxicillin.
Ann Emerg Med. 2007 Sep;50(3):350, 359.
PMID: 17709052
- McNamara K, Hughes OB, Strowd LC.
Cutaneous drug eruptions including serum sickness-like reaction, symmetrical
drug-related intertriginous and flexural exanthema, and drug-induced lupus.
Clin Dermatol. 2020 Nov - Dec;38:641-647.
PMID: 33341198
- NEJM Knowledge+